Guillaume Maby

Guillaume MABY currently serves as the Regional Brand Lead for Europe International in Onco-Haematology and has held multiple leadership roles at Jazz Pharmaceuticals since July 2019, including Business Unit Director for Neuroscience and Sleep. Previously, Guillaume MABY was the Head of Sales for the Neurology & Immunology Business Unit at MERCK France from October 2017 to June 2019. Earlier career experience includes various positions at Novartis from April 2005 to September 2017, such as Multiple Sclerosis First Line Manager and Alzheimer Brand Manager. Academic credentials include a Master in Management des Industries Pharmaceutiques et Technologies Médicales from iaelyon School of Management and an IUP in Ingenierie de la santé from Université Paul Sabatier Toulouse III.